EIC Accelerator

Iktos is a French company specializing in artificial intelligence-driven solutions for medicinal chemistry and new drug discovery. It offers SaaS platforms Makya™ for generative drug design and Spaya™ for retrosynthesis, accelerating pharmaceutical R&D. Iktos also develops AI-driven synthesis automation platform Iktos Robotics and has its own drug pipeline targeting oncology and autoimmune diseases.

Hummink is a company specializing in additive manufacturing technology, focusing on nano-printing solutions that enable precise design and manufacturing at the nanoscale. Founded in 2020 in Paris by Amin M'barki, Pascal Boncenne, Lydéric Bocquet, Alessandro Siria, and Antoine Nigues, Hummink utilizes a patented technology that integrates a nanometric pen with an oscillating microresonator. This innovative approach allows for the capillary deposition of various liquids, equipping clients in the semiconductor and molecular diagnostic industries with the capability to create large objects while maintaining exceptional resolution and precision on substrates ranging from millimetric to centimetric scales.

Hummink is a company specializing in additive manufacturing technology, focusing on nano-printing solutions that enable precise design and manufacturing at the nanoscale. Founded in 2020 in Paris by Amin M'barki, Pascal Boncenne, Lydéric Bocquet, Alessandro Siria, and Antoine Nigues, Hummink utilizes a patented technology that integrates a nanometric pen with an oscillating microresonator. This innovative approach allows for the capillary deposition of various liquids, equipping clients in the semiconductor and molecular diagnostic industries with the capability to create large objects while maintaining exceptional resolution and precision on substrates ranging from millimetric to centimetric scales.

Laclarée is a French company based in Lyon, founded in 2016, that specializes in developing adaptive eyeglasses specifically designed to correct presbyopia. The company's innovative product incorporates patented fluid technology, allowing the eyeglasses to automatically adjust to different viewing distances in real-time. This advancement aims to address the needs of individuals aged 45 and older who are often dissatisfied with traditional vision correction solutions, such as progressive lenses or the use of multiple pairs of glasses. By combining adaptive lens technology with refractive correction capabilities for conditions like astigmatism, myopia, and hyperopia, Laclarée seeks to provide a more effective solution for clear vision across various distances.

Diamante is a company based in Verona, Italy, that specializes in the development and manufacturing of diagnostic devices for autoimmune diseases, utilizing innovative nanomaterials. Founded in 2016, the company leverages plants as bioreactors to produce nanoparticles derived from modified plant viruses. This approach allows Diamante to create advanced tools for diagnosing and potentially treating autoimmune conditions, focusing on sustainable and efficient production methods. Through its research and development efforts, Diamante aims to contribute significantly to the field of autoimmune disease therapy.

Atamyo Therapeutics is a biotechnology company based in Paris, France, established in 2020 by Stephane Degove and Isabelle Richard. The company is dedicated to developing innovative gene therapies aimed at treating neuromuscular diseases, particularly muscular dystrophies. Atamyo focuses on creating safer and more effective gene therapies by exploring novel approaches for gene replacement. Its research includes the development of specialized delivery systems designed to minimize side effects and enhance the restoration of normal physiological function in patients suffering from these challenging conditions. Through its advancements in gene therapy, Atamyo Therapeutics aims to improve the quality of life for individuals affected by neuromuscular disorders.

Omini is a biotechnology company based in Saint Mandé, France, founded in 2019. It specializes in the development of portable and multipurpose bio-sensing devices designed for immediate blood testing. Omini's biosensor platform enables the simultaneous detection of multiple biomarkers, providing personalized blood biomarker data that can be utilized to customize therapies and prevent acute crises in patients with chronic conditions. By leveraging multiplex electrochemical biosensor technology, the company offers affordable and accurate monitoring solutions that facilitate decentralized testing and at-home monitoring, ultimately helping to alleviate the burden on healthcare systems. Omini primarily serves general practitioners, aiming to enhance patient care through innovative diagnostic tools.

Atamyo Therapeutics is a biotechnology company based in Paris, France, established in 2020 by Stephane Degove and Isabelle Richard. The company is dedicated to developing innovative gene therapies aimed at treating neuromuscular diseases, particularly muscular dystrophies. Atamyo focuses on creating safer and more effective gene therapies by exploring novel approaches for gene replacement. Its research includes the development of specialized delivery systems designed to minimize side effects and enhance the restoration of normal physiological function in patients suffering from these challenging conditions. Through its advancements in gene therapy, Atamyo Therapeutics aims to improve the quality of life for individuals affected by neuromuscular disorders.

Laclarée is a French company based in Lyon, founded in 2016, that specializes in developing adaptive eyeglasses specifically designed to correct presbyopia. The company's innovative product incorporates patented fluid technology, allowing the eyeglasses to automatically adjust to different viewing distances in real-time. This advancement aims to address the needs of individuals aged 45 and older who are often dissatisfied with traditional vision correction solutions, such as progressive lenses or the use of multiple pairs of glasses. By combining adaptive lens technology with refractive correction capabilities for conditions like astigmatism, myopia, and hyperopia, Laclarée seeks to provide a more effective solution for clear vision across various distances.

Omini is a biotechnology company based in Saint Mandé, France, founded in 2019. It specializes in the development of portable and multipurpose bio-sensing devices designed for immediate blood testing. Omini's biosensor platform enables the simultaneous detection of multiple biomarkers, providing personalized blood biomarker data that can be utilized to customize therapies and prevent acute crises in patients with chronic conditions. By leveraging multiplex electrochemical biosensor technology, the company offers affordable and accurate monitoring solutions that facilitate decentralized testing and at-home monitoring, ultimately helping to alleviate the burden on healthcare systems. Omini primarily serves general practitioners, aiming to enhance patient care through innovative diagnostic tools.

Laclarée is a French company based in Lyon, founded in 2016, that specializes in developing adaptive eyeglasses specifically designed to correct presbyopia. The company's innovative product incorporates patented fluid technology, allowing the eyeglasses to automatically adjust to different viewing distances in real-time. This advancement aims to address the needs of individuals aged 45 and older who are often dissatisfied with traditional vision correction solutions, such as progressive lenses or the use of multiple pairs of glasses. By combining adaptive lens technology with refractive correction capabilities for conditions like astigmatism, myopia, and hyperopia, Laclarée seeks to provide a more effective solution for clear vision across various distances.

Diamante is a company based in Verona, Italy, that specializes in the development and manufacturing of diagnostic devices for autoimmune diseases, utilizing innovative nanomaterials. Founded in 2016, the company leverages plants as bioreactors to produce nanoparticles derived from modified plant viruses. This approach allows Diamante to create advanced tools for diagnosing and potentially treating autoimmune conditions, focusing on sustainable and efficient production methods. Through its research and development efforts, Diamante aims to contribute significantly to the field of autoimmune disease therapy.

Delox is a Portuguese company focused on the design and development of bio-decontamination devices aimed at creating clean and biosafe environments. Founded in 2018 as a spin-off from the Faculty of Sciences of the University of Lisbon, Delox specializes in automatic bio-decontamination robots and has developed a proprietary solid formulation of hydrogen peroxide, known as DeloxHP. This innovation allows for the efficient production of compact and cost-effective bio-decontamination devices, including the Delox Box, which is ready for market use. The company’s technology is applicable in various sectors, including the sterilization of medical devices, room bio-decontamination in hospitals and the food industry, as well as the decontamination of laboratory equipment and environmental test chambers. Delox aims to provide non-toxic solutions that effectively combat microorganisms, catering to the health, pharmaceutical, biodefense, and space industries.

Moi Composites is an innovative tech start-up based in Milan, Italy, specializing in the 3D printing of custom products using advanced composite materials. Founded as a spinoff from Politecnico di Milano University, Moi has developed a patented continuous fiber manufacturing process that utilizes robotic arms to produce strong, lightweight objects in unique shapes and sizes without the constraints of traditional manufacturing methods. One of its notable achievements includes the creation of the MAMBO, a 6.5-meter boat made from continuous thermoset fiberglass, marking a significant milestone in additive manufacturing. Moi Composites serves various industries, including medical, marine, oil and gas, aerospace, and energy, providing tailored solutions that streamline the design and production process. The company has received multiple accolades for its technological advancements, positioning itself at the forefront of the composite manufacturing sector.

BetaGlue Technologies SpA is a Milan-based company that specializes in the development and manufacture of medical devices designed for loco-regional radiation therapy targeting unresectable solid tumors. The company's innovative product features a proprietary beta-emitting biocompatible matrix, which facilitates the controlled administration of radionuclides directly into tumor masses. This technology not only enhances the effectiveness of cancer treatment but also plays a crucial role in preventing complications that can arise following procedures such as lung and liver biopsies. By focusing on localized therapies, BetaGlue Technologies aims to improve patient outcomes and advance the field of cancer treatment.

Womed SAS, founded in 2018, is a medical device company that originated from research at Professor Garric's biopolymer lab at the University of Montpellier, France. The company focuses on addressing unmet medical needs in gynecologic surgery, particularly intrauterine adhesions, which can impact fertility and pregnancy. Womed develops insertable devices designed to act as mechanical barriers against adhesions, protecting the uterine cavity. These devices are engineered to break up, dissolve, and be naturally discharged without requiring intervention from healthcare professionals, thereby helping women reduce or prevent recurrent intrauterine adhesion formation and miscarriage.

Defacto Technologies SA is a chip design software company specializing in enhancing the design-for-test (DFT) process and improving the testability of integrated circuits and systems on chip (SoCs). Founded in 2003 and headquartered in Moirans, France, with an additional office in Sunnyvale, California, the company offers a comprehensive suite of electronic design automation (EDA) tools. This includes HiDFT-SIGNOFF, which facilitates scan logic insertion at the register transfer level (RTL), and HiDFT-STAR, a customizable tool for editing RTL designs of IP cores and SoC blocks. Defacto Technologies also provides RTL testability debug and signoff, as well as RTL DFT verification solutions. Its software serves various industries, including automotive, mobile, virtual reality, and artificial intelligence, enabling clients to develop advanced SoCs with enhanced functionality and lower power consumption. The company has established a global presence with sales offices across China, Japan, Taiwan, South Korea, Singapore, Israel, and Europe.

Toopi Organics is a biotechnology company based in Langon, France, established in 2019. It develops microbiological and agricultural technologies to transform human urine into fertilizers and biostimulants for agriculture. The company collects and upcycles human urine, depollutes and enriches it with microorganisms to provide natural, economical, and efficient alternatives to chemical fertilizers. Its products include Arbop and Vitip, which support plant growth and crop health, offering farming communities an environmentally conscious option for nutrient supply.

Founded in 2016, SAALG Geomechanics specializes in real-time ground analysis software for civil works and building projects. It offers machine learning-driven solutions to anticipate ground movement issues, along with numerical models calibrations, soil parameter characterization, and geotechnical consulting services.

AEInnova develops autonomous industrial monitoring devices for predictive maintenance. Its flagship device InduEye is battery-free, self-powered, and capable of edge computing for real-time vibration, thermal, and steam-trap monitoring, powered by waste heat with optional solar or wind energy. It uses LoRaWAN or NB-IoT/LTE-CAT M for communications and streams data to cloud dashboards with analytics, alarms, and environmental impact analysis. The system aims to reduce downtime and maintenance costs through non-invasive, self-sustaining monitoring. Certifications include CE and ATEX/IECEX, with FCC ongoing. The technology is deployed across sectors such as oil and gas, aluminium, steel, paper, rubber, water treatment, and energy, with customers including Repsol, Cepsa, ArcelorMittal, Enel, and others. AEInnova has been recognized as a leading EU scale-up with multiple awards and EC funding, and participates in EU R&D initiatives related to energy harvesting and high-temperature IoT.